Stay updated with breaking news from Single Dose. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Oral presentation of encore clinical data from Phase 3 clinical trials of exa-cel -- Oral and poster presentations on quality-of-life impacts of sickle cell disease or transfusion-dependent beta-thalassemia and burden of hematopoietic stem cell transplant -BOSTON and ZUG, Switzerland--(BUSINESS WIRE)--Vertex Pharm...
Sermonix Pharmaceuticals Announces Poster Presentation on Phase 1 Ethnobridging Study of Lasofoxifene at the 12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research — Translating Knowledge Into Practice - read this article along with other careers information, tips and advice on BioSpace
Katrine Finderup Nielsen and colleagues investigate vaccine effectiveness against SARS-CoV-2 reinfection, COVID-19 related hospitalization and COVID-19 related death, in previously infected individuals in Denmark.
Uniindia: Mumbai, Nov 3 (UNI) Pharma major, Alembic Pharma on Thursday said it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ketorolac Tromethamine Injection USP, 15 mg/mL, 30 mg/mL, and 60 mg/2 mL (30 mg/mL) Single Dose Vials.
Anti-diabetic, anti-dyslipidemia, and anti-oxidant activity of Discopodium penninervum Hoschst leaf in both in vitro and in vivo